Sphera Funds Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Sphera Funds Management’s Portfolio VIRX Stock Details VIRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-20,623	Closed	-$299K	–	116
2020 Q1	$299K	Sell	20,623 -40,571	-66%	-$881K	0.05%	73
2019 Q4	$723K	Hold	61,194	–	–	0.1%	82
2019 Q3	$1.54M	Buy	+61,194	New	+$1.77M	0.25%	68
2017 Q4	–	Sell	-3,193	Closed	-$217K	–	157
2017 Q3	$217K	Sell	3,193 -2,327	-42%	-$190K	0.04%	121
2017 Q2	$522K	Buy	5,520 +1,949	+55%	+$224K	0.11%	110
2017 Q1	$513K	Hold	3,571	–	–	0.13%	101
2016 Q4	$453K	Buy	+3,571	New	+$497K	0.14%	92
2015 Q3	–	Sell	-5,881	Closed	-$3.72M	–	146
2015 Q2	$3.72M	Sell	5,881 -309	-5%	-$164K	0.55%	65
2015 Q1	$3.19M	Buy	+6,190	New	+$3.12M	0.45%	75

Other funds holding VIRX

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return